Clinical
What is the 'hyperopic reserve' in pre-myopia?
In this article:
Prevention or delay of myopia onset can have a potentially greater impact on an individual’s final level of myopia, compared to short-term myopia control treatment outcomes. This article explores the concept of a ‘hyperopic reserve’, which is protective against myopia development, with new data indicating ethnicity could influence the amount of reserve required.
The rising prevalence of myopia worldwide elicits an increasing need to delay the onset of myopia, as well as reduce its progression. Several interventions have shown efficacy in slowing myopia progression and many of these treatments are beginning to be incorporated into eye care practitioners’ myopia management strategies. But what also must be considered are the ways in which children at high risk of developing myopia – otherwise called ‘pre-myopia’, can be effectively managed.
Defining pre-myopia
The International Myopia Institute (IMI) - Defining and Classifying Myopia report1 clearly defines the pre-myope as follows.
Pre-myopia – a refractive state of an eye of ≤ 0.75 D and > 0.50 D in children where a combination of baseline refraction, age, and other quantifiable risk factors provide a sufficient likelihood of the future development of myopia to merit preventative interventions.
Pre-myopic children are recognised as individuals who have a nonmyopic refraction, but who have a cluster of risk factors and/or an observed pattern of eye growth that indicates a high risk of progression to myopia. The key risk factors are outlined below, as identified by the IMI.2
- Family history – one myopic parent increases risk by 2-3 fold, while two myopic parents increases risk by 3-5 fold.3-6
- Visual environment – less than two hours day spent outdoors increases risk7, especially if combined with more than 3 hours a day spent on near work activities (outside of school time).3
- Binocular vision – Children with higher accommodative convergence (AC/A) ratios, typically seen with esophoria, have an increased risk of myopia development within one year of over 20 times.4 Accommodative lag may also be a risk factor but there is conjecture.5 Intermittent exotropia has also been associated with a higher incidence of myopia.6
- Current refraction – the most significant risk factor of this lot for future myopia is if a child exhibits +0.75D or less of manifest hyperopia at age 6-7.8 This risk is independent of family history and visual environment. New data indicates that this widely known figure may be higher for children of East Asian ethnicity, compared to the multi-ethnic North American cohort (more info below) from which this was originally determined. Understanding this figure provides the concept of 'hyperopic reserve'.
Pre-myopes are an important population as these represent children who do not yet require vision correction, but are at imminent risk of doing so based on their risk factors and growth trajectory. There is a need to investigate interventions for pre-myopia, as children with early-onset myopia have a longer course of the disease, and they are more likely to develop higher levels of myopia.9
Intervention matters, because the overall impact of myopia prevention appears to outweigh that of short-term myopia control in children who are already myopic. This is because delaying the onset of myopia by 1 year can reduce final myopia by around 0.75D - similarly effective as 2-3 years of myopia control with existing modalities.10
Hyperopic reserve is a safety net for myopia development
Human eyes are shortest at birth and hyperopia is the predominant refractive error. Myopia arises through childhood commonly due to early emmetropization of the eye, along with a failure of mechanisms to maintain emmetropic status with continued eye growth in older children.11 Compared to emmetropes, children who develop myopia undergo accelerated axial elongation up to 3 years before, with the most rapid growth in the year prior to onset.12 Within this brief window there is a rapid shedding of age-normal hyperopia that overshoots emmetropia, into myopia.
Identifying ideal candidates is crucial to the accurate application of any treatment. It is well known that the biggest risk factor for developing myopia is being less hyperopic than age-normal – or having a low 'hyperopic reserve'. A child with reduced baseline hyperopia than expected for their age is at greater risk for developing myopia sooner, while more hyperopia has a protective effect.8 Directing attention to pre-myopia interventions for children with insufficient hyperopic reserve is an important strategy to reduce the incidence and severity of myopia.
A given level of hyperopia can be protective against development of myopia, and this is termed the hyperopic reserve.8
What level of hyperopic reserve is required?
Since a more hyperopic baseline refraction is helpful for reducing the risk of developing myopia, this raises some clinical considerations. What level of hyperopic reserve is required to reduce myopia risk? And does a child’s age and ethnicity affect the protective hyperopic reserve threshold? Three studies have investigated this crucial value in pre-myopia.
In 2023, Chen et al examined longitudinal data among Chinese children for the dose-response relationship between hyperopic reserve and future risk of myopia.13 The data spanned visits for over 870,000 patients from 2005 to 2021 and children aged 4 to 18 years. Concerningly, it was found that the mean age of myopia onset reduced by three years over that time, from 10.6 years in 2005 to 7.6 years in 2021. When it came to understanding hyperopic reserve, a dose-response relationship was found, where the risk of myopia increased rapidly when the spherical equivalent refractive error (SERE) was less than +1.50D. With SERE’s less than +1.50D, the risk (hazard ratio) of myopia increased by 0.325 for each 0.10D reduction in hyperopic reserve. In this large cohort of Chinese children, the 'safety threshold' of hyperopic reserve was +1.50D, regardless of age and gender.
Figure 1: Dose-response relationship between hyperopic reserve and future risk of myopia. SERE – spherical equivalent refractive error. HR – hazard ratio. This is Figure 5 from the open-access paper by Chen et al 2023.13
Another paper investigating hyperopic reserve was an observational study by Wang et al published in 2024.14 This study aimed to generate age-specific normative values of hyperopic reserve and annual myopic shift in Chinese children aged 3 to 16 years, based on data collected from 3118 participants over a 1-year period (2015-2016). Values for hyperopic reserve were extrapolated using a backward calculation method. Individuals who were non-myopes at age 17 were taken as a starting point, then looking at their range of refractions at age 16, age 15 and so on, with this stepwise analysis continued until reaching the youngest age group available in the database. Key cut points for the mean hyperopic reserve within this population of Chinese children were +2.08D at 6 years, +1.49D at 8 years and +1.04D at 10 years.14
Figure 2: Bar graph showing age-specific hyperopic reserve by backward calculation. This is Figure 2 from the open-access paper by Wang et al 202414, with the summary table created by Myopia Profile.
By contrast, the well-known CLEERE study, used by the IMI in their 2019 definition of pre-myopia1, was an observational cohort study conducted in North America with data collected from 4512 children aged 6 to 11 years (36% White, 22% Hispanic, 16% African American, 12% Native American, 14% Asian American). SERE was the single best predictive factor for myopia onset. A hyperopic reserve of at least +0.75D was cited as the cut-off for myopia risk in children aged 6 years, with lower hyperopic reserve for older children.12
Cut points for predicting future myopia to grade 8 (age 13 years). Each baseline grade 1 through 6 (ages 6-11 years) is represented with 2 to 7 possible subsequent grades after baseline. This is Figure 1 from the open-access paper by Zadnik et al 2015,12 with the summary table created by Myopia Profile.
Notably, the threshold for hyperopic reserve for the CLEERE study’s ethnically diverse population, is much lower compared to the two studies of Chen et al13 and Wang et al14 undertaken in Chinese children. The lower threshold likely stems from ethnic differences between the study populations.
Unlike the CLEERE study’s ethnically diverse cohort (where only 14% were of Asian ethnicity), the other two studies were ethnically Chinese populations, who tend to have higher baseline risks for myopia and faster myopia progression after onset.6 Chen et al13 did not find a progressive reduction hyperopic reserve threshold with age, compared with the other two studies - it is unclear why. Altogether, these studies contribute significant data on the identification of pre-myopes and thus the candidates for early intervention.
Management of pre-myopia
The main evidence-based strategy for children at risk of developing myopia is increasing outdoor time as a first-line intervention (with sun protection).2 Limiting continuous periods of near work (< 30-45 minutes) and close working distances (< 20-30 cm) can be considered, as these are modifiable risk factors.15
More proactive treatment options with an evidence base are as follows, each showing similar propensity to reduce the rates of myopia onset by about half - meaning half the rate of axial length progression and/or half the rate of myopia incidence.
- Essilor® Stellest® plano spectacle lenses. For those willing to comply with spectacle wear, optical treatment with plano highly aspherical lenslet target (HALT) lenses have minimal side effects, and efficacy data has recently been shown, provided wearing time of at least 30 hours per week is met.16 Read more in our Science Summary Spectacles with highly aspherical lenslets for pre-myopia and our newly published Q&A Interview on The ‘hyperopic reserve’ and treatment in pre-myopia - Q&A with Dr Peter Chen.
- Low-dose atropine. Low-dose atropine has shown efficacy in a handful of studies, although the ideal concentration between 0.01% and 0.05% appears to show age and ethnicity variation.17-20 Read more in Atropine for pre-myopia.
- Repeated low-level red light (RLRL) therapy. RLRL therapy also has recent efficacy data for delaying myopia onset in pre-myopic children.21 Read more in our Science Summary Can red light therapy delay myopia onset?
The current management options for pre-myopia include visual environment advice such as spending at least two hours per day outdoors22 and limiting excessive near work.23 Treatment options with an evidence base for delaying myopia onset include low-dose atropine, highly aspherical lenslet target (HALT) spectacle lenses, and RLRL therapy.
While the options are fewer compared to the available optical and pharmacological treatments for slowing myopia progression after onset, the impact of pre-myopia treatment on a child’s final myopia is comparable if not greater than two to three years of myopia control.10 While we can't be sure if we can 'prevent' myopia onset in children at risk, there is a volume of evidence indicating the crucial value of intervention to delay onset, and the available interventions to do so.
Meet the Authors:
About Brian Peng
Brian is a clinical optometrist based in Sydney, Australia. He graduated with a Master of Clinical Optometry from the University of New South Wales in 2020.
Read Brian's work on our My Kids Vision website, our public awareness platform. Brian also works on development of various new resources across MyopiaProfile.com.
References
- Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, Rahi J, Resnikoff S, Vitale S, Yannuzzi L. IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30.
- Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, Liu YM, Michaud L, Mulder J, Orr JB, Rose KA, Saunders KJ, Seidel D, Tideman JWL, Sankaridurg P. IMI - Clinical Management Guidelines Report. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203.
- Jones LA, Sinnott LT, Mutti DO, Mitchell GL, Moeschberger ML, Zadnik K. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3524-32.
- French AN, Morgan IG, Mitchell P, Rose KA. Risk factors for incident myopia in Australian schoolchildren: the Sydney adolescent vascular and eye study. Ophthalmology. 2013 Oct;120(10):2100-8.
- Jiang X, Tarczy-Hornoch K, Cotter SA, Matsumura S, Mitchell P, Rose KA, Katz J, Saw SM, Varma R; POPEYE Consortium. Association of Parental Myopia With Higher Risk of Myopia Among Multiethnic Children Before School Age. JAMA Ophthalmol. 2020 May 1;138(5):501-509.
- Morgan IG, Wu PC, Ostrin LA, Tideman JWL, Yam JC, Lan W, Baraas RC, He X, Sankaridurg P, Saw SM, French AN, Rose KA, Guggenheim JA. IMI Risk Factors for Myopia. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):3.
- Xiong S, Sankaridurg P, Naduvilath T, Zang J, Zou H, Zhu J, Lv M, He X, Xu X. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017 Sep;95(6):551-566.
- Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, Twelker JD, Mutti DO; Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study Group. Prediction of Juvenile-Onset Myopia. JAMA Ophthalmol. 2015 Jun;133(6):683-9.
- Gwiazda J, Hyman L, Dong LM, Everett D, Norton T, Kurtz D, Manny R, Marsh-Tootle W, Scheiman M; Comet Group. Factors associated with high myopia after 7 years of follow-up in the Correction of Myopia Evaluation Trial (COMET) Cohort. Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):230-7.
- Bullimore MA, Brennan NA. Myopia: An ounce of prevention is worth a pound of cure. Ophthalmic Physiol Opt. 2023 Jan;43(1):116-121.
- Flitcroft DI. Emmetropisation and the aetiology of refractive errors. Eye (Lond). 2014 Feb;28(2):169-79.
- Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, Cotter SA, Kleinstein RN, Manny RE, Twelker JD, Zadnik K; CLEERE Study Group. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2510-9.
- Chen Z, Gu D, Wang B, Kang P, Watt K, Yang Z, Zhou X. Significant myopic shift over time: Sixteen-year trends in overall refraction and age of myopia onset among Chinese children, with a focus on ages 4-6 years. J Glob Health. 2023 Nov 9;13:04144.
- Wang J, Qi Z, Feng Y, Chen J, Du L, Yang J, Xie H, Zhu J, Zou H, He X, Xu X. Normative value of hyperopia reserve and myopic shift in Chinese children and adolescents aged 3-16 years. Br J Ophthalmol. 2024 Jun 20;108(7):1024-1029.
- Ip JM, Saw SM, Rose KA, Morgan IG, Kifley A, Wang JJ, Mitchell P. Role of near work in myopia: findings in a sample of Australian school children. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2903-10.
- Zhang Z, Zeng L, Gu D, Wang B, Kang P, Watt K, Zhou J, Zhou X, Chen Z, Yang D, Chen C, Wang X, Zhou X, Chen Z. Spectacle Lenses With Highly Aspherical Lenslets for Slowing Axial Elongation and Refractive Change in Low-Hyperopic Chinese Children: A Randomized Controlled Trial. Am J Ophthalmol. 2024 Aug 27;269:60-68.
- Fang PC, Chung MY, Yu HJ, Wu PC. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010 Aug;26(4):341-5.
- Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol. 2022 Jan;70(1):238-240.
- Wang W, Zhang F, Yu S, Ma N, Huang C, Wang M, Wei L, Zhang J, Fu A. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr. 2023 Jun;182(6):2597-2606.
- Yam JC, Zhang XJ, Zhang Y, Yip BHK, Tang F, Wong ES, Bui CHT, Kam KW, Ng MPH, Ko ST, Yip WWK, Young AL, Tham CC, Chen LJ, Pang CP. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA. 2023 Feb 14;329(6):472-481.
- He X, Wang J, Zhu Z, Xiang K, Zhang X, Zhang B, Chen J, Yang J, Du L, Niu C, Leng M, Huang J, Liu K, Zou H, He M, Xu X. Effect of Repeated Low-level Red Light on Myopia Prevention Among Children in China With Premyopia: A Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e239612.
- Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019 Jul 21;16(14):2595.
- Li SM, Li SY, Kang MT, Zhou Y, Liu LR, Li H, Wang YP, Zhan SY, Gopinath B, Mitchell P, Wang N; Anyang Childhood Eye Study Group. Near Work Related Parameters and Myopia in Chinese Children: the Anyang Childhood Eye Study. PLoS One. 2015 Aug 5;10(8):e0134514.
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.